This from a "draft" obtained by Sarah Lueck of the WSJ.
We all know how reliable Waxman's savings estimates are. Remember the $200 billion in savings from using the VA restrictive formulary approach and the $70 billion in savings from follow-on biologics. So here comes Waxman raking in $150 over ten years through price controls and restrictive formularies ala Medicaid.
I hope the Democrats go down the "Destroy Part D" path again. It was fun last time.